OUP MANAGEMENT CO., LLC
Adviser information for OUP MANAGEMENT CO., LLC last updated from Form ADV on March 28th, 2024. Select data displayed; additional Form ADV, Form D, Form 13F and other data is available from the Fincoded API.
Advisory Business
| Type of Organization | Limited Liability Company |
|---|---|
| Fiscal Year End | DECEMBER |
| Legal Location | Delaware, United States |
Employees
| Total Number of Employees | 0 |
|---|---|
| Investment Advisory/Research | 0 |
| Registered Broker-Dealer Representatives | 0 |
| Registered State Investment Advisers | 0 |
| Licensed Agents of an Insurance Company | 0 |
| No. of Firms/People that Solicit Clients | 0 |
RAUM
| Provides Management of Securities Portfolios | No |
|---|
Clients
| Type | Number | RAUM |
|---|---|---|
| Individuals | 0 | $0 |
| HNW Individuals | 0 | $0 |
| Banking or thrift institutions | 0 | $0 |
| Investment companies | 0 | $0 |
| Business development companies | 0 | $0 |
| Pooled investment vehicles | 0 | $0 |
| Pension and profit sharing plans | 0 | $0 |
| Charitable organizations | 0 | $0 |
| State or municipal gov entities | 0 | $0 |
| Other investment advisers | 0 | $0 |
| Insurance companies | 0 | $0 |
| Sovereign wealth funds and foreign official institutions | 0 | $0 |
| Corporations or other businesses | 0 | $0 |
| Other | 0 | $0 |
| Type | Number |
|---|---|
| No. of Non-RAUM Clients | 0 |
| No. of Non-U.S. Clients | 0 |
Services
| Advisory Services | – |
|---|---|
| Compensation | – |
Principal Office
50 MONUMENT ROAD, SUITE 201BALA CYNWYD
PA
United States
Monday - Friday, 8:30AM EST - 5:00PM EST
Tel: 484-434-2255, Fax: 484-434-2256
Chief Compliance Officer
NoneIndustry Affiliates
| OSAGE GP II, LLC | Sponsor, GP, manager of pooled investment vehicles |
| OSAGE GP III, LLC | Sponsor, GP, manager of pooled investment vehicles |
| OSAGE GP IV, LLC | Sponsor, GP, manager of pooled investment vehicles |
| OSAGE GP V, LLC | Sponsor, GP, manager of pooled investment vehicles |
| OSAGE GP VI, LLC | Sponsor, GP, manager of pooled investment vehicles |
| OSAGE UNIVERSITY GP II, LLC | Sponsor, GP, manager of pooled investment vehicles |
| OSAGE UNIVERSITY GP III, LLC | Sponsor, GP, manager of pooled investment vehicles |
| OSAGE UNIVERSITY GP IV, LLC | Sponsor, GP, manager of pooled investment vehicles |
| OSAGE UNIVERSITY GP, LLC | Sponsor, GP, manager of pooled investment vehicles |
| OVP MANAGEMENT CO., LLC | Other investment adviser, including financial planners |
| UNIVERSITY PARTNERS I, LP | Sponsor, GP, manager of pooled investment vehicles |
| UNIVERSITY PARTNERS II, LP | Sponsor, GP, manager of pooled investment vehicles |
| UNIVERSITY PARTNERS III, LP | Sponsor, GP, manager of pooled investment vehicles |
| UNIVERSITY PARTNERS IV, LP | Sponsor, GP, manager of pooled investment vehicles |
Private Funds
| Name | Type | Assets $USD | Min Investment $USD | No. Owners |
|---|---|---|---|---|
| OSAGE UNIVERSITY PARTNERS I, LP | Venture Capital Fund | $52.3M | $0.1M | 101 |
| OSAGE UNIVERSITY PARTNERS II, LP | Venture Capital Fund | $184.3M | $0.1M | 176 |
| OSAGE UNIVERSITY PARTNERS III, LP | Venture Capital Fund | $294.1M | $0.1M | 180 |
| OSAGE UNIVERSITY PARTNERS IV, LP | Venture Capital Fund | $219.2M | $0.1M | 126 |
Control Persons
| Name | Type | Entity | Title | Since | Ownership |
|---|---|---|---|---|---|
| HARRINGTON, WILLIAM, T | Individual | – | MANAGING MEMBER | 01/2018 | 25-50% |
| SINGER, MARC, A. | Individual | – | MANAGING MEMBER | 01/2018 | 25-50% |
| OSAGE INDUSTRIES | Domestic Entity | – | MANAGING MEMBER | 01/2021 | 25-50% |
| ADELSON, ROBERT, S | Individual | OSAGE INDUSTRIES | SHAREHOLDER | 05/1990 | > 75% |
| Dunnous, Claudia | Individual | – | CFO | 01/2018 | < 5% |
| Cohen, Matthew, E. | Individual | – | MANAGING MEMBER | 10/2022 | 25-50% |
No. Employees, Historic
Holdings
From latest 13F, filed November 9th, 2023 for period ending September 30th, 2023
| Name | Class | Value $USD | # Shares | Private Fund |
|---|---|---|---|---|
| eFFECTOR Therapeutics, Inc. | Common Stock | 615K | 1M | – |
| PMV Pharmaceuticals, Inc. | Common Stock | 6M | 989K | – |
| Cyteir Therapeutics, Inc. | Common Stock | 7M | 2M | – |
| Homology Medicines, Inc. | Common Stock | 75K | 64K | – |
| Ikena Oncology, Inc. | Common Stock | 116K | 27K | – |
| Precision BioSciences, Inc. | Common Stock | 384K | 1M | – |
| Selecta Biosciences, Inc. | Common Stock | 914K | 863K | – |
| Spero Therapeutics, Inc. | Common Stock | 301K | 249K | – |
| Centessa Pharmaceuticals plc | Sponsored ADS | 19M | 3M | – |
| Aerovate Therapeutics Inc. | Common Stock | 8M | 604K | – |
| Graphite Bio | Common Stock | 1M | 406K | – |
| Vor Biopharma Inc. | Common Stock | 794K | 375K | – |